Medicon Valley Alliance and Citi would like to welcome you to a boost seminar November 14th in Copenhagen, from 8.30 to 13.30 including networking lunch.
The event is a convening forum for senior executives of life sciences, biotechnology, medical technology, and other healthcare companies to learn about key trends driving the investor perspectives, recent developments in the international capital raising environment and expanding your business globally, by acquisitions and organically.
We look forward to welcoming you!
Date: Thursday 14th of November 2024
Time: 8:30 – 13:30
Venue: Moltkes Palæ, Dronningens Tværgade 2, 1302 København K, Denmark
Program
| 8:30 | Arrival, registration and networking |
| 9:00 | Welcome and introduction to Citi and Medicon Valley Alliance Karolina Burmeister, Head of Citi Commercial Bank Nordics David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance |
| 9:05 | Future of Healthcare and Deglobalization Adam Spielman, Head of Healthcare, Citi Global Insights will present his views on the effects of deglobalization on global healthcare delivery, drug development and related trade flows, in light of the upcoming Trump administration. He will also talk to his latest investor reports on GLP-1 ‘Wonder-Drugs’ and the impact of AI. |
| 10:00 | How to attract growth capital Nanna Lüneborg, General Partner at Forbion Dan Iacopetti, Nordic Equity Capital Markets at Citi – Moderator of the discussion |
| 10:45 | Networking break |
| 11:15 | Best practices in international expansion Oliver Rey Beckstrom, Commercial Banking Healthcare Industry Head EMEA at Citi Nicolas Escribano, Director at MV Credit Kaare Daugaard Hansen, Director, Finance Operations – Head of Treasury and PtP at Ascendis Pharma |
| 12:00 | Lunch and networking Lunch is provided |
| 13:30 | End of Boost Seminar |
 |
Adam Spielman, Head of Health and Consumer at Citi Global Insights In the health area, his overarching thesis is that in time, healthcare will become more preventative, more personalized, and more convenient, thanks to the convergence of the health, tech and consumer industries. In the consumer area he focuses on the Future of Food. Previously he was head of EMEA Consumer Staples Research at Citi. He was ranked the #1 tobacco analyst for more than a decade. He also covered the beverages, food and HPC sectors at various times. He joined Citi 1997 and was appointed managing director in 2014. Adam has an MBA from Harvard, where he graduated as a Baker Scholar, and an MA in Engineering and Philosophy from Cambridge University. |
 |
Nanna Lüneborg is General Partner at Forbion Prior to joining Forbion, Nanna was a Partner at Novo Ventures and a key member of the European deal team focussing on late-stage biopharma investments across Europe. During her 10 years at Novo, Nanna was involved in numerous successful European growth stage investments including high-profile cross-over deals and IPOs. Notable investments led by Nanna include NBE Therapeutics GmbH, which was later acquired by Boehringer Ingelheim, LAVA Therapeutics N.V. (NASDAQ: LVTX) Orphazyme A/S (ORPHA.CO; ORPH), Inventiva S.A. (NASDAQ: IVA – Euronext Paris: IVA), ObsEva SA (NASDAQ: OBSV; SIX: OBSN), Numab Therapeutics AG, Nodthera Limited and ReViral Ltd. Nanna began her career in venture capital at Apposite Capital and worked as a Senior Business Analyst at Cancer Research UK. Nanna holds an MBA from the University of Cambridge, a PhD in Neuroscience from University College London, and a BA in Physiology and Psychology from the University of Oxford. |
 |
Dan Iacopetti, Head of Nordic ECM at Citi Dans team has been ranked the #1 international bank for Nordic ECM in 3 of the last 5 years (Dealogic). Dan joined Citi in 2014 and is a Managing Director. In addition to experience in the Nordics, Dan has significant ECM transaction experience in Italy, Israel, the UK and Germany. Prior to Citi, Dan began his career in the infrastructure business of the Macquarie Group, with having a primary focus on both principal investment and advisory work in the Transport Infrastructure space. Dan holds a degree in Economics (BSc, Hons.) from the University of Warwick and has been identified as a Financial News “top 40 under 40” for EMEA Investment Banking. |
 |
Oliver Rey Beckstrom, Citi Commercial Bank industry head for Healthcare and Consumer & Retail for Europe, MEA and UK Oliver leads the industry client coverage organisation that helps mid-sized companies with rapid growth and international expansion by providing them with Citi’s full product platform. He has 25 years of experience across commercial banking, corporate banking, investment banking and capital markets, and is a Senior Credit Officer.His CCB responsibilities have included formation and leadership of the CCB corporate finance team, being a Country Head (UK, Czech Rep. & Slovakia), supporting the launch of new markets in UK and Western Europe, and launch of the CCB ESG team. Oliver is the Citi Commercial Bank industry head for Healthcare and Consumer & Retail for Europe, MEA and UK. He leads the industry client coverage organisation that helps mid-sized companies with rapid growth and international expansion by providing them with Citi’s full product platform. He has 25 years of experience across commercial banking, corporate banking, investment banking and capital markets, and is a Senior Credit Officer. His CCB responsibilities have included formation and leadership of the CCB corporate finance team, being a Country Head (UK, Czech Rep. & Slovakia), supporting the launch of new markets in UK and Western Europe, and launch of the CCB ESG team. Oliver holds a BSc (Econ) in Economics from the London School of Economics and a Masters in Finance from CUNEF. |
 |
Nicolas Escribano, Director in the Direct Lending Investment Team at MV Credit Nicolas Escribano is a Director in the Direct Lending Investment Team at MV Credit since 2016, working on originating and structuring Direct Lending and Subordinated Debt financings. MV Credit is a pan-European private credit specialist with nearly 25 years of investment experience providing tailored financing solutions to European companies across senior direct lending, subordinated direct lending, hybrid, and CLO strategies. The firm focuses on sustainable lending across the capital structure backing companies in defensive industries, owned by private equity sponsors. MV Credit has a successful track record of financing businesses in the healthcare industry, having invested over €2.5bn in healthcare companies over the past 10 years, supporting growth and internationalisation business plans. Healthcare is a core industry for MV Credit, having represented >40% of total investments done. Within healthcare, MV Credit has supported businesses in subsectors such as medical devices and consumables, testing equipment and supplies, pharma and pharma devices, healthcare communications and healthcare software and IT solutions, amongst others. In the Nordics, MV Credit has supported Atos Medical, Diaverum, Dako (currently owned by Agilent) and Gambro (currently owned by Baxter) among other healthcare businesses. Prior to MV Credit, Nicolas worked in the Debt Capital Markets Origination and Structuring Team at Santander in New York. Nicolas holds a Bachelor’s degree (first class) in Economics from Carlos III University in Madrid. |
 |
Kaare Daugaard Hansen,Head of Treasury and PTP at Ascendis Pharma Kaare Daugaard Hansen is the Head of Treasury and PTP at Ascendis Pharma, where he oversees the treasury function and leads the Procure-to-Pay processes. With over 15 years of experience in finance and treasury management, Kaare has held key roles in both corporate treasury and treasury consulting. He holds an MSc in Business Administration from Copenhagen Business School. |
| Co-organized by | |
 |
 |